The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis

References

• Albert DM, Raven ML. Ocular tuberculosis. Microbiol Spectr. 2016; 4(6). doi:10.1128/microbiolspec.TNMI7-0001-2016.
   PubMed Web of Science ®Google Scholar
• Willermain F, Caspers L, Celia W, Makhoul D. Tuberculosis and Immunosuppressive Treatment in Uveitis Patients. London: InTech Open Limited, 2019.
   Google Scholar
• Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the collaborative ocular tuberculosis study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102.
   PubMed Web of Science ®Google Scholar
• Gupta V, Gupta a, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta a, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146(5):772–779. doi:10.1016/j.ajo.2008.06.011.
   PubMed Web of Science ®Google Scholar
• Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116(7):1391–1396. doi:10.1016/j.ophtha.2009.02.005.
   PubMed Web of Science ®Google Scholar
• Agarwal a, Agrawal R, Gunasekaran DV, et al. The collaborative ocular tuberculosis study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2019;27(3):465–473. doi:10.1080/09273948.2017.1406529.
   PubMed Web of Science ®Google Scholar
• Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6–9. doi:10.1136/bjophthalmol-2016-309531.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
   PubMed Web of Science ®Google Scholar
• Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189–2194. doi:10.1056/NEJMsr077003.
   PubMed Web of Science ®Google Scholar
• Basu S, Nayak S, Padhi TR, Das T. Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting. Eye (Lond). 2013;27(5):657–662. doi:10.1038/eye.2013.5.
   PubMed Web of Science ®Google Scholar
• Kee AR, Gonzalez-Lopez JJ, Al-Hity a, et al. Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi:10.1016/j.survophthal.2016.03.001.
   PubMed Web of Science ®Google Scholar
• Spratt a, Key T, Vivian AJ. Chronic anterior uveitis following bacille calmette-guerin vaccination: molecular mimicry in action? J Pediatr Ophthalmol Strabismus. 2008;45(4):252–253. doi:10.3928/01913913-20080701-15.
   PubMed Web of Science ®Google Scholar
• Pantoja a, Kik SV, Denkinger CM. Costs of novel tuberculosis diagnostics–will countries be able to afford it? J Infect Dis. 2015;211(Suppl 2):S67–77. doi:10.1093/infdis/jiu820.
   PubMedGoogle Scholar
• Zanetti S, Bua a, Molicotti P, Maiore I, Pinna a. QuantiFERON-TB gold assay on plasma for confirmation of presumed tuberculosis-related uveitis. J Clin Microbiol. 2016;54(8):2175–2177. doi:10.1128/JCM.00848-16.
   PubMedGoogle Scholar
• Singh R, Gupta V, Gupta a. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–125.
   PubMedGoogle Scholar
• Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm. 2018;26(6):865–869. doi:10.1080/09273948.2017.1296580.
   PubMed Web of Science ®Google Scholar
• Al-Qarni a, Abouammoh MA, Almousa AN, Mousa a, Abu El-Asrar AM. Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia. Int Ophthalmol. 2019;39(2):317–333. doi:10.1007/s10792-017-0815-9.
   PubMedGoogle Scholar
• Ang M, Hedayatfar a, Wong W, Chee SP. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol. 2012;96(3):332–336. doi:10.1136/bjophthalmol-2011-300209.
   PubMed Web of Science ®Google Scholar
• Khochtali S, Gargouri S, Abroug N, et al. The spectrum of presumed tubercular uveitis in Tunisia, North Africa. Int Ophthalmol. 2015;35(5):663–671. doi:10.1007/s10792-014-9992-y.
   PubMed Web of Science ®Google Scholar
• Babu K, Satish V, Prakash O, Subbakrishna DK, Murthy KR. Role of the mantoux test and treatment with antitubercular therapy in a South Indian patient population of presumed intraocular tuberculosis. Ocul Immunol Inflamm. 2009;17(5):307–311. doi:10.3109/09273940902999349.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Kim KE, Woo SJ, Park KH. The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea. Korean J Ophthalmol. 2014;28(3):226–233. doi:10.3341/kjo.2014.28.3.226.
   PubMedGoogle Scholar
• Babu K, Satish V, Satish S, Subbakrishna DK, Abraham MP, Murthy KR. Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation. Indian J Ophthalmol. 2009;57(6):427–430. doi:10.4103/0301-4738.57147.
   PubMed Web of Science ®Google Scholar
• Campos WR, Henriques JF, Kritski AL, Curi a, Pimentel RT, Spindola de Miranda S. Tuberculous uveitis at a referral center in southeastern Brazil. J Bras Pneumol. 2008;34(2):98–102. doi:10.1590/s1806-37132008000200006.
   PubMedGoogle Scholar
• Chung CY, Li KKW. The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region. Int Ophthalmol. 2018;38(6):2273–2282. doi:10.1007/s10792-017-0716-y.
   PubMed Web of Science ®Google Scholar
• Shahidatul-Adha M, Zunaina E, Liza-Sharmini AT, et al. Ocular tuberculosis in Hospital Universiti Sains Malaysia - a case series. Ann Med Surg (Lond). 2017;24:25–30. doi:10.1016/j.amsu.2017.10.003.
   PubMedGoogle Scholar
• Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, et al. Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence. Br J Ophthalmol. 2016;100(3):348–355. doi:10.1136/bjophthalmol-2014-306474.
   PubMed Web of Science ®Google Scholar
• Cimino L, Herbort CP, Aldigeri R, Salvarani C, Boiardi L. Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol. 2009;29(2):67–74. doi:10.1007/s10792-007-9071-8.
   PubMedGoogle Scholar
• Conant MM, Vrasich CR, Wongskhaluang JV, et al. Role of the infectious disease consultant in management of patients with tuberculosis-associated ocular inflammation. Open Forum Infect Dis. 2015;3(1):ofv195. doi:10.1093/ofid/ofv195.
   PubMedGoogle Scholar
• Damato EM, Dawson S, Liu X, et al. a retrospective cohort study of patients treated with anti-tuberculous therapy for presumed ocular tuberculosis. J Ophthalmic Inflamm Infect. 2017;7(1):23. doi:10.1186/s12348-017-0141-4.
   PubMed Web of Science ®Google Scholar
• Jakob E, Max R, Zimmermann S, et al. Three years of experience with QuantiFERON-TB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22(6):478–484. doi:10.3109/09273948.2013.866255.
   PubMed Web of Science ®Google Scholar
• Psilas K, Aspiotis M, Petroutsos G, Kalogeropoulos C, Constantopoulos S. Antituberculosis therapy in the treatment of peripheral uveitis. AnnOphthalmol. 1991;23:254–258.
   Web of Science ®Google Scholar
• Ang M, Wong W, Ngan CC. Chee SP Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond). 2012;26(5):658–665. doi:10.1038/eye.2012.1.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Testi I, Bodaghi B, et al. Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on the management of tubercular uveitis - report 2: guidelines for initiating anti-tubercular therapy in anterior uveitis, intermediate uveitis, panuveitis and retinal vasculitis [published online ahead of print, 2020 Jun 27]. Ophthalmology. 2020;S0161-6420(20)30598–4. doi:10.1016/j.ophtha.2020.06.052.
   Google Scholar
• Ang L, Kee a, Yeo TH, et al. Treatment outcome in patients with presumed tubercular uveitis at a tertiary referral eye care centre in Singapore. Int Ophthalmol. 2018;38(1):11–18. doi:10.1007/s10792-016-0401-6.
   PubMed Web of Science ®Google Scholar